Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry. 1994

A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
Servicio General de Citometria, Universidad de Salamanca, Spain.

In the present study the usefulness of a method combining multiple staining direct immunofluorescence technique together with flow cytometry in order to predict relapse in ALL is analyzed in a group of 47 patients (11 T-ALL and 36 B-ALL). Results show that this method can be applied to at least two-thirds of all ALL patients being specially useful for the T-ALL cases (100% vs 56%) as this corresponding to the incidence of "aberrant" phenotypes. The detection of an increase in the percentage of bone marrow cells displaying "aberrant" phenotypes in two consecutive samples from the same patient is of great help on predicting relapse (sensitivity of 92% and specificity of 75%).

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D015703 Antigens, CD Differentiation antigens residing on mammalian leukocytes. CD stands for cluster of differentiation, which refers to groups of monoclonal antibodies that show similar reactivity with certain subpopulations of antigens of a particular lineage or differentiation stage. The subpopulations of antigens are also known by the same CD designation. CD Antigen,Cluster of Differentiation Antigen,Cluster of Differentiation Marker,Differentiation Antigens, Leukocyte, Human,Leukocyte Differentiation Antigens, Human,Cluster of Differentiation Antigens,Cluster of Differentiation Markers,Antigen Cluster, Differentiation,Antigen, CD,CD Antigens,Differentiation Antigen Cluster,Differentiation Marker Cluster,Marker Cluster, Differentiation

Related Publications

A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
September 1990, Journal of immunological methods,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
December 1991, American journal of hematology,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
May 2013, Klinische Padiatrie,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
March 2005, British journal of haematology,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
August 1999, Cytometry,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
January 1986, Annals of the New York Academy of Sciences,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
January 2017, Medical journal, Armed Forces India,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
June 2005, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
January 2001, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
A Orfao, and J Ciudad, and M C Lopez-Berges, and A Lopez, and B Vidriales, and M D Caballero, and B Valverde, and M Gonzalez, and J F San Miguel
April 2016, Medical journal, Armed Forces India,
Copied contents to your clipboard!